US 9415105
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted A61KA61K2039/55561A61K31/00
Quick answer
US patent 9415105 (Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/55561, A61K31/00, A61K31/365, A61K31/519